Azulfidine

This page contains recent news articles, when available, and an overview of Azulfidine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Azulfidine
(when available)

Pharmacology and use:
Sulfasalazine is an anti-inflammatory indicated for the treatment of ulcerative colitis and rheumatoid arthritis. For the treatment of Crohn's Disease and Rheumatoid Arthritis as a second-line agent

Mechanism Of Action:
The mode of action of Sulfasalazine or its metabolites, 5-aminosalicylic acid (5-ASA) and sulfapyridine (SP), is still under investigation, but may be related to the anti-inflammatory and/or immunomodulatory properties that have been observed in animal and in vitro models, to its affinity for connective tissue, and/or to the relatively high concentration it reaches in serous fluids, the liver and intestinal walls, as demonstrated in autoradiographic studies in animals. In ulcerative colitis, clinical studies utilizing rectal administration of Sulfasalazine, SP and 5-ASA have indicated that the major therapeutic action may reside in the 5-ASA moiety. The relative contribution of the parent drug and the major metabolites in rheumatoid arthritis is unknown.

News Articles on Sulfasalazine

Brand Names/Synonyms:
Azulfidine is also known by the following brand names and/or synonymsAccucol; Alti-Sulfasalazine; Asulfidine; Azlufidine En-Tabs; Azopyrin; Azopyrine; Azulfidine; Azulfidine En-Tabs; Benzosulfa; Colo-Pleon; Pms-Sulfasalazine; Pms-Sulfasalazine E.C.; Reupirin; Rorasul; S.A.S. 500; S.A.S. Enteric-500; S.A.S.-500; Salazopiridazin; Salazopyridin; Salazopyrin; Salazopyrin En-Tabs; Salazosulfapyridin; Salazosulfapyridine; Salicylazosulfapyridine; Salisulf; Sulcolon; Sulfasalazin; Sulfasalazine; Sulphasalazine; W-T Sasp Oral

Drug Category:
Azulfidine is categorized under the following by the FDA: Antirheumatic Agents; Gastrointestinal Agents; Anti-inflammatory Agents; Anti-Infectives; Sulfonamides; ATC:A07EC01

Dosage Forms:
TABLET

Absorption:
Not Available

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
2-hydroxy-5-[4-(pyridin-2-ylsulfamoyl)phenyl]azo-benzoicacid





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy